Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carvedilol for Cardiotoxicity Prevention in Cancer Patients on Anthracyclines
NCT04939883Phase 4Active, not recruiting
- Sponsor
- Hospital Sírio-Libanês
- Start
- Aug 2021
- Primary completion
- May 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of carvedilol in Cardiotoxicity, sponsored by Hospital Sírio-Libanês. Started Aug 2021; status: active, not recruiting.
02
Drugs
carvedilol
03
Conditions
Cardiotoxicity
Beyond the preview
Go deeper on NCT04939883.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04939883.